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INTRODUCTION
Epidemiological studies have shown that chronic
arsenic exposure increases the risk of developing
vascular diseases and cancers of the skin, bladder,
liver, kidney, and lung, as well as skin lesions in hu-
man. The International Agency for Research on Can-
cer (IARC) categorizes arsenic and its compounds
as known human carcinogens (1). On the other
hand, purified arsenic trioxide (Trisenox) is being
successfully used in treatment of acute promyelo-
cytic leukemia (APL), chronic myelogenous leuke-
mia (CML), multiple myeloma (MM), hematologi-
cal malignancies, and even solid tumors (2). Path-
ways for arsenite uptake into cells have been discov-
ered only recently. Aquaglyceroporins (AQGPs), a
subgroup of the water channel family are transmem-
brane proteins that transport water as well as glyc-
erol and neutral hydroxides, Sb(OH)3 or As(OH)3,
which are structurally similar to glycerol (3 - 4).
G1pF, the glycerol facilitator in Escherichia coli was
first identified as a trivalent metalloid transporter
(5), then Fps1p, an yeast homolog of G1pF in S.
cerevisiae (6), and AQP7, 9 in mammalian cells
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(7) were all proved to be transporters of arsenite.
Xenopus laevis oocytes exhibited increased transport
of 73As(III) after microinjection with either AQP7
or AQP9 cRNA (7). The results from site-directed
mutagenesis showed As(OH)3 and glycerol use the
same translocation pathway in AQP9 (8). Pretreat-
ment of cultured primary mouse hepatocytes with
an AQP9 inhibitor and siRNA-mediated knockdown
of AQP9 decreased uptake of arsenite (9). Up-regu-
lation of AQP9 expression by vitamin D or all-trans
retinoic acid (ATRA) in HL60, a leukemia cell line,
resulted in cell hypersensitivity to Trisenox and en-
hanced cytotoxicity (10-11). However, until recently,
most of these studies were conducted in prokaryo-
tes or primitive eukaryotes, and mostly in vitro . The
uptake route of arsenite in mammals in vivo is still
less defined. In this study, we focus on gastrointesti-
nal tissues to study the route of arsenite uptake in
vivo .
METHODS
Cell culture and treatments Caco-2 cells, a human
intestinal epithelial cell line, were maintained in
DMEM (Dulbecco’s Modified Eagle Medium) sup-
plemented with 10% fetal bovine serum, 100 units/
ml penicillin and 100 μg/ml streptomycin. MTT as-
say was performed to detect the toxicity of differ-
ent concentrations of As(III) to Caco-2 cells. Cells
were cultured on 6 cm-dishes overnight and treated
with nontoxic concentration of 32 μM As(III) or 10
μMHg(II)+32 μM As(III) for 2 h. After having been
washed three times with normal saline, the cells in
each dish were immersed in 3 ml fuming HNO3 and
incubated overnight at room temperature. The so-
lution was transferred to an acid-washed beaker and
hydrolyzed with 3 ml HNO3 and 3 ml 30% H2O2 on
a 100electric hot plate. The concentrations of in-
organic arsenite (iAs) in Caco-2 cells were meas-
ured by graphite furnace atomic absorption spectros-
copy (GFAAS).
Animals and treatments Thirty-two adult male ICR
mice with a mean body weight of 20.00.5 g from
the animal center of Nantong University were used.
The animals were maintained according to the
guideline of NIH. The mice were administered by
lavage with normal saline (n=8), 10 mg/kg As(III)
(n=8), 10 mg/kg As(III) after 10 mg/kg Hg(II) (n=
8), and a mixture of equivalent volume of glycerol
and As(III) (n=8), respectively. The mice were sac-
rificed 2 h after administration, and the middle parts
of stomach and small intestine were removed for
measurement. Concentrations of iAs in gastrointesti-
nal tissues were determined by GFAAS after diges-
tion with fuming HNO3 and H2O2 (12). The levels of
iAs in the blood and the small intestine were meas-
ured by GFAAS in a semi in vivo study after As(III),
Hg(II)+As(III), or glycerol+As(III) was injected
into the middle-part of ligated small intestine of
anesthetized mice.
Reverse Transcription-Polymerase Chain Reaction
(RT-PCR) Total RNA were extracted from both gas-
trointestinal tissues and Caco-2 cells with Trizol re-
agent. RT-PCR was performed for mRNA expres-
sion of AQP3, 7, 9, and β -actin genes.
RESULTS
Caco-2 cells were treated with 32 μM As(III) for
2 h, with or without pre-treatment for 30 min with
10 μMHg(II), a specific inhibitor of AQPs. The con-
centrations of iAs in the cells of Hg(II)+As(III)-
treated group significantly decreased to 21.43.6
ng/4106 cells compared with As(III) treated group
(32.57.4 ng/4106 cells). This result indicates
that Hg(II) suppressed iAs accumulation in Caco-2
cells
Next, the gastrointestinal tract of mice was lav-
aged/incubated at high dose of 10 mg/kg arsenic
trioxide (1/3 LD50, a tolerated concentration), and/
or 10 mg/kg mercuric chloride or glycerol. After 2
h treatment, the accumulation of iAs in gastrointesti-
nal tissues was measured. The result showed that
arsenite uptake was suppressed by a specific inhibi-
tor (Hg(II)) and by a competitive inhibitor (glyc-
erol) of AQGPs. Similar results were obtained un-
der semi in vivo condition.
Lastly, the expression of AQP3, 7, and 9 in gas-
trointestinal tissues was detected by RT-PCR analy-
sis. AQP3 was expressed in both stomach and in-
testines, while AQP9, in stomach and AQP7, intes-
tines only. Furthermore, the expressions of AQP3
and AQP9 were also detected in Caco-2 cells.
DISCUSSION
Arsenite is mainly absorbed by gastrointestinal tis-
sues especially by the small intestine, then distrib-
uted to other tissues and organs by way of blood-
stream. By control the intestinal arsenite uptake
quantitatively, it would become possible to control
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the amount of total arsenite redistribution among
every tissue throughout the body. In this study,
pathways of uptake arsenite into gastrointestinal tis-
sues were explored.
AQPs are a family of hydrophobic, integral mem-
brane proteins. Among 13 identified mammalian
AQPs (AQP0-12), AQGPs (AQP3, 7, 9, and 10)
have been proven to transport glycerol and other
small solutes as well as water (13). AQGPs are
widely expressed in mammals. Here we detected
expressions of AQP3 and 9 in stomach of mice and
in human intestinal epithelial cell line Caco-2, and
AQP3 and 7 in small intestine tissues. iAs accumu-
lated in gastrointestinal tissues and Caco-2 cells af-
ter administration of As(III). We found the expres-
sion levels of AQGPs differed in different parts of
the gastrointestinal tissues ; e.g. , duodenum and je-
junum as the main absorption positions expressed
higher level of AQP3 than ileum. The expression
level of AQP3 in the stomach was higher than that
in small intestines, while the concentration of iAs
in stomach (108.429.1 μg/g) was much higher
than that in intestines (13.52.5 μg/g). However,
whether AQP3 is the major transporter of arsenite
in mammals is still obscure. Liu et al. showed that
human AQP9 was more effective As(III) transporter
than hAQP7, while little or no As(III) was trans-
ported by hAQP3 or hAQP10 (8). On the other
hand, Lee et al. , using RNA interference and ectopic
expression, verified that AQP3 participates in As
(III) uptake in lung adenocarcinoma cells (1). Our
results may give more supportive evidences to the
possibility that AQP3 is also an As(III) transporter.
Hg(II) is a specific inhibitor for most of the AQPs,
which binds to a unique cysteine residue (C189) lo-
cates at the narrowest segment of AQP water chan-
nels. Once the Hg(II) ion binds to the sulfhydryl
side chain at a channel-lining position, the transpor-
tation of water and solutes by AQPs will be blocked
(14). In cultured human intestinal epithelial cell line,
we found the concentration of iAs was decreased in
Caco-2 cells by pre-treatment with Hg(II). Similar
results were obtained in vivo . Additionally, as a com-
petitive reagent of AQGPs, glycerol also interfered
the uptake of As(III) into gastrointestinal tissues.
All these results suggested that AQGPs could be
important transporters of As(III) not only for a par-
ticular mammalian cells but also for whole body in
mammals. Certainly, results in this report are pre-
liminary because mammals are complicated organ-
isms requiring more additional evidences to prove
if AQGPs is the only pathway in mammals or just
one of them.
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